Terms: = Head and neck cancer AND FAT1, CDHF7, 2195, ME5, hFat1, CDHR8 AND Prognosis
19 results:
1. Therapeutic Advances and Challenges for the Management of HPV-Associated Oropharyngeal cancer.
Muniz IAF; Araujo M; Bouassaly J; Farshadi F; Atique M; Esfahani K; Bonan PRF; Hier M; Mascarella M; Mlynarek A; Alaoui-Jamali M; Silva SDD
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612819
[TBL] [Abstract] [Full Text] [Related]
2. Data mining on identifying diagnosis and prognosis biomarkers in head and neck squamous carcinoma.
Ju G; Yao Z; Zhao Y; Zhao X; Liu F
Sci Rep; 2023 Jun; 13(1):10020. PubMed ID: 37340028
[TBL] [Abstract] [Full Text] [Related]
3. Genome-wide DNA methylation profiling of HPV-negative leukoplakia and gingivobuccal complex cancers.
Inchanalkar M; Srivatsa S; Ambatipudi S; Bhosale PG; Patil A; Schäffer AA; Beerenwinkel N; Mahimkar MB
Clin Epigenetics; 2023 May; 15(1):93. PubMed ID: 37245006
[TBL] [Abstract] [Full Text] [Related]
4. Noninvasive genomic profiling of somatic mutations in oral cavity cancers.
Xi Y; Negrao MV; Akagi K; Xiao W; Jiang B; Warner SC; Dunn JD; Wang J; Symer DE; Gillison ML
Oral Oncol; 2023 May; 140():106372. PubMed ID: 37004423
[TBL] [Abstract] [Full Text] [Related]
5. Identification of tumor mutation burden-associated molecular and clinical features in cancer by analyzing multi-omics data.
Li M; Gao X; Wang X
Front Immunol; 2023; 14():1090838. PubMed ID: 36911742
[TBL] [Abstract] [Full Text] [Related]
6. Loss of CDKN2A/B is a Molecular Marker of High-grade Histology and is Associated with Aggressive Behavior in Acinic Cell Carcinoma.
Dogan S; Xu B; Rana S; Chen H; Ghossein RA; Berger MF; Ho AL; Katabi N
Mod Pathol; 2023 Jul; 36(7):100150. PubMed ID: 36841437
[TBL] [Abstract] [Full Text] [Related]
7. Inactivation of Hippo pathway characterizes a poor-prognosis subtype of esophageal cancer.
Mai Z; Yuan J; Yang H; Fang S; Xie X; Wang X; Xie J; Wen J; Fu J
JCI Insight; 2022 Aug; 7(16):. PubMed ID: 35993362
[TBL] [Abstract] [Full Text] [Related]
8. Genomic Hippo Pathway Alterations and Persistent YAP/TAZ Activation: New Hallmarks in head and neck cancer.
Faraji F; Ramirez SI; Anguiano Quiroz PY; Mendez-Molina AN; Gutkind JS
Cells; 2022 Apr; 11(8):. PubMed ID: 35456049
[TBL] [Abstract] [Full Text] [Related]
9. Clinical significance of fat1 gene mutation and mRNA expression in patients with head and neck squamous cell carcinoma.
Kim SI; Woo SR; Noh JK; Lee MK; Lee YC; Lee JW; Ko SG; Eun YG
Mol Oncol; 2022 Apr; 16(8):1661-1679. PubMed ID: 34939311
[TBL] [Abstract] [Full Text] [Related]
10. Whole-exome sequencing identifies biosignatures that predict adverse survival outcomes in surgically treated patients with oral cavity squamous cell carcinoma.
Liao CT; Yang LY; Lee LY; Lin CY; Wang HM; Ng SH; Yen TC; Fan WL; Hsieh JC
Oral Oncol; 2021 Nov; 122():105547. PubMed ID: 34700279
[TBL] [Abstract] [Full Text] [Related]
11. Germline variants in DNA repair genes are associated with young-onset head and neck cancer.
Cury SS; Miranda PM; Marchi FA; Canto LMD; Chulam TC; Petersen AH; Aagaard MM; Pinto CAL; Kowalski LP; Rogatto SR
Oral Oncol; 2021 Nov; 122():105545. PubMed ID: 34598035
[TBL] [Abstract] [Full Text] [Related]
12. Significance of Circular fat1 as a Prognostic Factor and Tumor Suppressor for Esophageal Squamous Cell Carcinoma.
Takaki W; Konishi H; Shoda K; Arita T; Kataoka S; Shibamoto J; Furuke H; Takabatake K; Shimizu H; Komatsu S; Shiozaki A; Fujiwara H; Masuda K; Otsuji E
Ann Surg Oncol; 2021 Dec; 28(13):8508-8518. PubMed ID: 34185205
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic value of tumor mutational burden in patients with oral cavity squamous cell carcinoma treated with upfront surgery.
Moreira A; Poulet A; Masliah-Planchon J; Lecerf C; Vacher S; Larbi Chérif L; Dupain C; Marret G; Girard E; Syx L; Hoffmann C; Jeannot E; Klijanienko J; Guillou I; Mariani O; Dubray-Vautrin A; Badois N; Lesnik M; Choussy O; Calugaru V; Borcoman E; Baulande S; Legoix P; Albaud B; Servant N; Bieche I; Le Tourneau C; Kamal M
ESMO Open; 2021 Aug; 6(4):100178. PubMed ID: 34118772
[TBL] [Abstract] [Full Text] [Related]
14. A molecular signature of well-differentiated oral squamous cell carcinoma reveals a resistance mechanism to metronomic chemotherapy and novel therapeutic candidates.
Kina S; Kawabata-Iwakawa R; Miyamoto S; Arasaki A; Sunakawa H; Kinjo T
J Drug Target; 2021 Dec; 29(10):1118-1127. PubMed ID: 33979258
[TBL] [Abstract] [Full Text] [Related]
15. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in head and neck cancer.
Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
[No Abstract] [Full Text] [Related]
16. Differential mutation spectrum and immune landscape in African Americans versus Whites: A possible determinant to health disparity in head and neck cancer.
Chaudhary S; Dam V; Ganguly K; Sharma S; Atri P; Chirravuri-Venkata R; Cox JL; Sayed Z; Jones DT; Ganti AK; Ghersi D; Macha MA; Batra SK
Cancer Lett; 2020 Nov; 492():44-53. PubMed ID: 32738272
[TBL] [Abstract] [Full Text] [Related]
17. The molecular landscape of the University of Michigan laryngeal squamous cell carcinoma cell line panel.
Mann JE; Kulkarni A; Birkeland AC; Kafelghazal J; Eisenberg J; Jewell BM; Ludwig ML; Spector ME; Jiang H; Carey TE; Brenner JC
Head Neck; 2019 Sep; 41(9):3114-3124. PubMed ID: 31090975
[TBL] [Abstract] [Full Text] [Related]
18. Genetically-defined novel oral squamous cell carcinoma cell lines for the development of molecular therapies.
Fadlullah MZ; Chiang IK; Dionne KR; Yee PS; Gan CP; Sam KK; Tiong KH; Ng AK; Martin D; Lim KP; Kallarakkal TG; Mustafa WM; Lau SH; Abraham MT; Zain RB; Rahman ZA; Molinolo A; Patel V; Gutkind JS; Tan AC; Cheong SC
Oncotarget; 2016 May; 7(19):27802-18. PubMed ID: 27050151
[TBL] [Abstract] [Full Text] [Related]
19. Association between fat1 mutation and overall survival in patients with human papillomavirus-negative head and neck squamous cell carcinoma.
Kim KT; Kim BS; Kim JH
Head Neck; 2016 Apr; 38 Suppl 1(Suppl 1):E2021-9. PubMed ID: 26876381
[TBL] [Abstract] [Full Text] [Related]
